Moses technology, also known as Moses Laser Enucleation of the Prostate (MoLEP), has emerged as a groundbreaking advancement in the field of urology, particularly in the management of benign prostatic hyperplasia (BPH) which commonly affects elderly men. This innovative surgical technique utilises a state-of-the-art high power (P 120) holmium laser specifically designed for the treatment of kidney stones and BPH. The revolutionary approach of MoLEP has redefined prostate surgery, offering a more effective and minimally invasive solution with numerous benefits for patients.
The MoLEP procedure employs pulse modulation through bubble technology, leveraging the physics of the holmium laser to achieve efficient microdissection of targeted tissue and the fragmentation of stones. This advanced laser technology delivers superior outcomes with 44% higher enucleation efficiency compared to conventional holmium pulse techniques. The procedure has significantly transformed the landscape of prostate surgery, offering a groundbreaking alternative to traditional treatments such as transurethral resection of the prostate (TURP) and open prostatectomy.
Prostate problems in older men, often associated with benign prostatic hyperplasia, can lead to various urinary symptoms and complications. As men age, hormonal changes can cause the prostate gland to enlarge, leading to urinary difficulties and other health issues. The innovative MoLEP procedure has been particularly beneficial for elderly patients with co-morbidities, offering a minimally invasive and highly effective treatment option. A case study of a 92-year-old patient with urinary blockage and recurrent urinary tract infections demonstrated the remarkable success of MoLEP in improving the patient’s quality of life. The procedure, completed in just 35 minutes under general anaesthesia, enabled the patient to regain independence in urination, eliminating the need for long-term catheterization and enhancing mobility.
The applications of Moses technology in BPH management are distinguished by their customised treatment plans tailored to individual patient needs. Its precision and reduced blood loss make it particularly suitable for treating larger prostates, making previously challenging cases more manageable. With its credibility, precision, and minimally invasive nature, Moses technology has instilled confidence among medical professionals in the effective management of BPH, ensuring safe and improved outcomes for patients.
Dr T Manohar, a renowned urologist and surgeon, has highlighted the incredible potential of Moses technology in transforming the approach to BPH management. The impact of this innovative technology extends beyond the realm of urological practice, offering new hope for patients suffering from benign prostatic hyperplasia and revolutionising the field of prostate surgery.
In conclusion, Moses Laser Enucleation of the Prostate (MoLEP) represents a significant milestone in modern urologic technology, heralding a new era in the management of benign prostatic hyperplasia. Its precision, minimally invasive nature, and exceptional success rates have positioned it as the future of prostate surgery, offering hope and improved quality of life for millions of elderly and high-risk individuals worldwide.
+ There are no comments
Add yours